|1.||Varki, Ajit: 6 articles (01/2014 - 09/2005)|
|2.||Padler-Karavani, Vered: 5 articles (09/2014 - 12/2008)|
|3.||Yu, Hai: 2 articles (03/2012 - 01/2009)|
|4.||Chen, Xi: 2 articles (03/2012 - 01/2009)|
|5.||Varki, Nissi M: 2 articles (01/2009 - 12/2008)|
|6.||Matsuda, Haruo: 2 articles (07/2006 - 10/2003)|
|7.||Reuven, Eliran Moshe: 1 article (05/2014)|
|8.||Amon, Ron: 1 article (05/2014)|
|9.||Leviatan Ben-Arye, Shani: 1 article (05/2014)|
|10.||Hsu, Yun: 1 article (02/2014)|
08/01/2012 - "The article reports on the historical use of mAbs and on very recent progress made in antitumor therapy using the anti-GD2 mAb and the antiganglioside mAbs, anti-N-glycolylneuraminic acid mAb and anti-Lewis mAb. Anti-GD2 is showing great promise in Phase III clinical trials in adjuvant treatment of neuroblastoma. "
02/01/2001 - "Only in the tumor ganglioside fraction, a small amount of N-glycolylneuraminic acid was found. "
07/01/1987 - "This tumor contained a significant amount of N-glycolyneuraminic acid (NGNA). "
01/01/2013 - "N-glycolylneuraminic acid (NeuGc)-containing gangliosides have been detected in some neoplasms in humans, although they are usually absent in normal human tissues. "
06/01/2010 - "Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells."
08/07/1998 - "Samples from mice with metastatic cancer showed a significant increase (67-200%) of total sialic acids mainly as a result of increased N-glycolylneuraminic acid synthesis. "
|3.||Melanoma (Melanoma, Malignant)
06/01/2001 - "The importance of ganglioside structure in the tumour-protective effect of GM3/VSSP vaccine was confirmed using GM3 containing N-glycolylneuraminic acid, a ganglioside absent in melanoma cells. "
03/01/1986 - "We have found the presence of gangliosides containing N-glycolylneuraminic acid in human melanoma tissues. "
02/01/1989 - "As antibody 32-27M detects N-glycolylneuraminic acid (NeuGc)-containing gangliosides, the effect of adding a number of different gangliosides to melanoma and astrocytoma cells cultured in the synthetic medium was studied. "
08/01/1993 - "The expression of N-glycolylneuraminic acid (NeuGc)-containing gangliosides in human melanoma cells grown both in culture and as xenografts in athymic (nu/nu) mice was analyzed extensively with specific mouse monoclonal antibodies (MAbs). "
09/28/2014 - "Additionally, dietary intake of the non-human Sia N-glycolylneuraminic acid (Neu5Gc) leads to natural metabolic-glycoengineering of human carcinomas that accumulate and express Neu5Gc. "
05/07/2014 - "N-Glycolylneuraminic acid (Neu5Gc) is a foreign immunogenic sugar in humans originating from the diet (e.g., red meat) and subsequently expressed on the cell surface, especially accumulating on carcinoma. "
02/01/1999 - "Serum and tissue specimens from healthy Wistar rats and from rats with Walker 256 carcinoma were analysed for N-acetyl and N-glycolylneuraminic acid by high performance liquid chromatography (HPLC) as per-O-benzoylated derivatives. "
02/01/1999 - "Analysis of N-acetyl and N-glycolylneuraminic acid in rat serum and tissues with Walker 256 carcinoma by high-performance liquid chromatography."
02/15/1991 - "Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry."
03/01/1984 - "Heterophile, Hanganutziu-Deicher (HD) antigen-active N-glycolylneuraminic acid-containing glycosphingolipids (GSLs) were detected as tumor-associated foreign antigens of a Marek's disease lymphoma-derived cell line, MSB1, by enzyme-immunoassay with chicken antibody against N-glycolylneuraminyl-lactosylceramide (anti-NeuGc-LacCer). "
|1.||N-Acetylneuraminic Acid (Sialic Acid)
|8.||1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
|10.||Biological Markers (Surrogate Marker)
|1.||Heterologous Transplantation (Xenotransplantation)